BR9712128A - Métodos e composições para lipidização de moléculas hidrofìlicas - Google Patents

Métodos e composições para lipidização de moléculas hidrofìlicas

Info

Publication number
BR9712128A
BR9712128A BR9712128-2A BR9712128A BR9712128A BR 9712128 A BR9712128 A BR 9712128A BR 9712128 A BR9712128 A BR 9712128A BR 9712128 A BR9712128 A BR 9712128A
Authority
BR
Brazil
Prior art keywords
compounds
lipidization
compositions
methods
disulfide
Prior art date
Application number
BR9712128-2A
Other languages
English (en)
Inventor
Wei-Chiang Shen
Jinghua Wang
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of BR9712128A publication Critical patent/BR9712128A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

''MéTODOS E COMPOSIçõES PARA LIPIDIZAçãO DE MOLéCULAS HIDROFìLICAS" Derivados de ácidos graxos de compostos contendo dissulfeto (por exemplo, peptídios ou proteínas contendo dissulfeto) que compreendem produtos conjugados a ácidos graxos com uma ligação dissulfeto são empregados para distribuição dos compostos a células mamíferas. Essa modificação aumenta acentuadamente a absorção dos compostos pelas células mamíferas com relação à taxa de absorção dos compostos conjugados, bem como prolonga a retenção no sangue e no tecido dos compostos. Além disso, a ligação dissulfeto no conjugado é bastante lábil in vivo e assim facilita a liberação intracelular e extracelular dos compostos intactos das metades de ácido graxo.
BR9712128-2A 1996-09-26 1997-09-26 Métodos e composições para lipidização de moléculas hidrofìlicas BR9712128A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72130696A 1996-09-26 1996-09-26
US4949997P 1997-06-13 1997-06-13
PCT/US1997/017282 WO1998013007A2 (en) 1996-09-26 1997-09-26 Methods and compositions for lipidization of hydrophilic molecules

Publications (1)

Publication Number Publication Date
BR9712128A true BR9712128A (pt) 2000-12-12

Family

ID=26727231

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712128-2A BR9712128A (pt) 1996-09-26 1997-09-26 Métodos e composições para lipidização de moléculas hidrofìlicas

Country Status (10)

Country Link
EP (1) EP1023316A4 (pt)
JP (1) JP2002515883A (pt)
KR (1) KR100691315B1 (pt)
CN (1) CN1127477C (pt)
AU (1) AU737865B2 (pt)
BR (1) BR9712128A (pt)
CA (1) CA2267179A1 (pt)
IL (1) IL129177A0 (pt)
NO (1) NO991465L (pt)
WO (1) WO1998013007A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169078B1 (en) 1998-05-12 2001-01-02 University Of Florida Materials and methods for the intracellular delivery of substances
TWI242000B (en) 1998-12-10 2005-10-21 Univ Southern California Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
GB0103877D0 (en) * 2001-02-16 2001-04-04 King S College London Novel Drug Delivery system
US20050054612A1 (en) * 2003-09-08 2005-03-10 Monahan Sean D. Delivery by labile hydrophobic modification of drugs
AU2004311796A1 (en) * 2003-12-31 2005-07-21 Centocor, Inc. Novel recombinant proteins with N-terminal free thiol
KR20090091145A (ko) 2006-10-27 2009-08-26 웨이-치앙 션 지질화된 인터페론 및 이의 용도
JP2010520286A (ja) * 2007-03-05 2010-06-10 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ Ｗｎｔ組成物およびその使用方法
WO2009105783A1 (en) * 2008-02-21 2009-08-27 Dermacare Neuroscience Institute Cosmetic and dermatological formulations of mntf peptides
EP3995489A3 (en) * 2013-02-28 2022-07-20 Tufts University Disulfide compounds for delivery of pharmaceutical agents
US20160082126A1 (en) * 2013-05-13 2016-03-24 Tufts University Nanocomplexes for delivery of saporin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5907030A (en) * 1995-01-25 1999-05-25 University Of Southern California Method and compositions for lipidization of hydrophilic molecules
EP0912195B1 (en) * 1996-06-25 2009-01-21 Pepscan Systems B.V. Vaccine comprising antigens bound to carriers through labile bonds

Also Published As

Publication number Publication date
CN1235594A (zh) 1999-11-17
EP1023316A4 (en) 2004-06-09
IL129177A0 (en) 2000-02-17
NO991465D0 (no) 1999-03-25
WO1998013007A8 (en) 1999-05-20
JP2002515883A (ja) 2002-05-28
CA2267179A1 (en) 1998-04-02
WO1998013007A2 (en) 1998-04-02
CN1127477C (zh) 2003-11-12
EP1023316A2 (en) 2000-08-02
AU737865B2 (en) 2001-09-06
KR100691315B1 (ko) 2007-03-12
AU4596797A (en) 1998-04-17
KR20000048608A (ko) 2000-07-25
NO991465L (no) 1999-05-10

Similar Documents

Publication Publication Date Title
Mosesson et al. Human fibrinogen heterogeneities: III. Identification of γ chain variants
Woods et al. Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments.
ES2111289T3 (es) Metodos y kits de diagnostico que emplean promotores de estres en mamiferos para determinar la toxicidad de un compuesto.
ES2046300T3 (es) Composicion para el tratamiento de la piel.
Dublet et al. Type XIV collagen, a new homotrimeric molecule extracted from fetal bovine skin and tendon, with a triple helical disulfide-bonded domain homologous to type IX and type XII collagens.
Biswas et al. Stimulation of collagenase production by collagen in mammalian cell cultures
EA199700143A1 (ru) Способ и композиция ждя липидизации гидрофильных молекул
BR9607383A (pt) Composição farmacêutica útil para a transfecção de um ácido nucléico e utilização desta composição
Lehto et al. Skeletal muscle injury—molecular changes in the collagen during healing
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
BR0016032A (pt) Colágeno
Sreter et al. The effect of cross reinnervation on the synthesis of myosin light chains
BR9712128A (pt) Métodos e composições para lipidização de moléculas hidrofìlicas
MacBeath et al. Tyrosine-rich acidic matrix protein (TRAMP) accelerates collagen fibril formation in vitro.
FR2773075B1 (fr) Utilisation d'activateurs de ppar-gamma en dermatologie
AR009098A1 (es) Una composicion para el acondicionamiento de la piel y metodos cosmeticos que comprenden la aplicacion sobre la piel de dicha composicion
Williams et al. Fibronectin. Effect of disulfide bond reduction on its physical and functional properties.
BR9810121A (pt) Utilização do acido petroselìnico nativo ou esterificado
Fujii et al. Biochemical properties of collagen from ligaments and periarticular tendons of the human knee
DK0506748T3 (da) Aminosyrer, peptider eller derivater deraf bundet til fedtstoffer
JPH03502919A (ja) 美容用薬剤および皮膚トリートメント用組成物
BLACK et al. The Ehlers‐Danlos syndrome: an analysis of the structure of the collagen fibres of the skin
Barany et al. Stretch-induced myosin light chain phosphorylation and stretch-release-induced tension development in arterial smooth muscle.
Fan et al. Estimation of total collagen and types I and III collagen in canine rotator cuff tendons
PT94982A (pt) Processo para a preparacao de peptidos com accao antagonista contra bradiquinina e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 47/54 (2017.01), A61K 9/127 (2006.0